Skip to main content
SpringerLink
Log in

Laser treatment for retinopathy of prematurity

  • Review Article
  • Published:
Lasers in Medical Science Aims and scope Submit manuscript

Abstract

Retinal development involves a complex coordination of events that may be affected by premature delivery, leading to retinopathy of prematurity (ROP), a potential blinding childhood disease. The avascular retina drives further disease progression, with laser ablation reducing unfavorable anatomic outcomes as well as maintaining visual acuity. Trials have stressed the importance of early identification and treatment of threshold and high-risk prethreshold disease to improve outcomes. Retinal ablation with laser photocoagulation should involve entire treatment of avascular retina with a confluent laser spot density, avoiding skip lesions. The current review highlights the use of laser photocoagulation in the treatment of ROP.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Terry TL (1944) Retrolental fibroplasia in the premature infant: v. further studies on fibroplastic overgrowth of the persistent tunica vasculosa lentis. Trans Am Ophthalmol Soc 42:383–396

    PubMed  CAS  Google Scholar 

  2. Goldberg MF (1997) Persistent fetal vasculature (PFV): an integrated interpretation of signs and symptoms associated with persistent hyperplastic primary vitreous (PHPV). LIV Edward Jackson Memorial Lecture. Am J Ophthalmol 124(5):587–626

    PubMed  CAS  Google Scholar 

  3. Michaelson IC (1948) Vascular morphogenesis in the retina of the cat. J Anat 82(3):167–174, 4

    Google Scholar 

  4. Ashton N, Cook C (1954) Direct observation of the effect of oxygen on developing vessels: preliminary report. Br J Ophthalmol 38(7):433–440

    Article  PubMed  CAS  Google Scholar 

  5. Xu Q et al (2004) Vascular development in the retina and inner ear: control by Norrin and Frizzled-4, a high-affinity ligand-receptor pair. Cell 116(6):883–895

    Article  PubMed  CAS  Google Scholar 

  6. Hughes S, Yang H, Chan-Ling T (2000) Vascularization of the human fetal retina: roles of vasculogenesis and angiogenesis. Invest Ophthalmol Vis Sci 41(5):1217–1228

    PubMed  CAS  Google Scholar 

  7. Chan-Ling T et al (2004) Desmin ensheathment ratio as an indicator of vessel stability: evidence in normal development and in retinopathy of prematurity. Am J Pathol 165(4):1301–1313

    Article  PubMed  CAS  Google Scholar 

  8. Chan-Ling T, Gock B, Stone J (1995) The effect of oxygen on vasoformative cell division. evidence that ‘physiological hypoxia’ is the stimulus for normal retinal vasculogenesis. Invest Ophthalmol Vis Sci 36(7):1201–1214

    PubMed  CAS  Google Scholar 

  9. Shweiki D et al (1992) Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359(6398):843–845

    Article  PubMed  CAS  Google Scholar 

  10. Smith LE (2008) Through the eyes of a child: understanding retinopathy through ROP (The Friedenwald lecture). Invest Ophthalmol Vis Sci 49(12):5177–5182

    Article  PubMed  Google Scholar 

  11. Hellstrom A et al (2001) Low IGF-I suppresses VEGF-survival signaling in retinal endothelial cells: direct correlation with clinical retinopathy of prematurity. Proc Natl Acad Sci USA 98(10):5804–5808

    Article  PubMed  CAS  Google Scholar 

  12. Heidary G, Vanderveen D, Smith LE (2009) Retinopathy of prematurity: current concepts in molecular pathogenesis. Semin Ophthalmol 24(2):77–81

    Article  PubMed  Google Scholar 

  13. Terry TL (1942) Fibroblastic overgrowth of persistent tunica vasculosa lentis in infants born prematurely: ii. report of cases-clinical aspects. Trans Am Ophthalmol Soc 40:262–284

    PubMed  CAS  Google Scholar 

  14. Tasman W et al (2006) Retinopathy of prematurity: the life of a lifetime disease. Am J Ophthalmol 141(1):167–174

    Article  PubMed  Google Scholar 

  15. Ashton N, Ward B, Serpell G (1953) Role of oxygen in the genesis of retrolental fibroplasia; a preliminary report. Br J Ophthalmol 37(9):513–520

    Article  PubMed  CAS  Google Scholar 

  16. Ashton N (1954) Pathological basis of retrolental fibroplasia. Br J Ophthalmol 38(7):385–396

    Article  PubMed  CAS  Google Scholar 

  17. Palmer EA et al (2005) 15-year outcomes following threshold retinopathy of prematurity: final results from the multicenter trial of cryotherapy for retinopathy of prematurity. Arch Ophthalmol 123(3):311–318

    Article  PubMed  Google Scholar 

  18. Cryotherapy for Retinopathy of Prematurity Cooperative Group (1988) Multicenter trial of cryotherapy for retinopathy of prematurity. preliminary results. Arch Ophthalmol 106(4):471–479

    Article  Google Scholar 

  19. Good WV (2004) Final results of the early treatment for retinopathy of prematurity (ETROP) randomized trial. Trans Am Ophthalmol Soc 102:233–248, Discussion 248–50

    PubMed  Google Scholar 

  20. (2000) Supplemental Therapeutic Oxygen for Pre threshold Retinopathy Of Prematurity (STOP-ROP), a randomized, controlled trial. I: primary outcomes. Pediatrics 105(2):295–310

  21. Askie LM, Henderson-Smart DJ, Ko H (2009) Restricted versus liberal oxygen exposure for preventing morbidity and mortality in preterm or low birth weight infants. Cochrane Database Syst Rev (1):CD001077

  22. Section on Ophthalmology American Academy of Pediatrics; American Academy of Ophthalmology; American Association for Pediatric Ophthalmology and Strabismus (2006) Screening examination of premature infants for retinopathy of prematurity. Pediatrics 117(2):572–576

    Google Scholar 

  23. Clark D, Mandal K (2008) Treatment of retinopathy of prematurity. Early Hum Dev 84(2):95–99

    Article  PubMed  Google Scholar 

  24. International Committee for the Classification of Retinopathy of Prematurity (2005) The International Classification of Retinopathy of Prematurity revisited. Arch Ophthalmol 123(7):991–999

    Google Scholar 

  25. Chiang MF et al (2007) Interexpert agreement of plus disease diagnosis in retinopathy of prematurity. Arch Ophthalmol 125(7):875–880

    Article  PubMed  Google Scholar 

  26. Lorenz B et al (2009) Wide-field digital imaging based telemedicine for screening for acute retinopathy of prematurity (ROP). Six-year results of a multicentre field study. Graefes Arch Clin Exp Ophthalmol 247(9):1251–1262

    Article  PubMed  Google Scholar 

  27. Ells AL et al (2003) Telemedicine approach to screening for severe retinopathy of prematurity: a pilot study. Ophthalmology 110(11):2113–2117

    Article  PubMed  Google Scholar 

  28. Schwartz SD et al (2000) Telemedical evaluation and management of retinopathy of prematurity using a fiberoptic digital fundus camera. Ophthalmology 107(1):25–28

    Article  PubMed  CAS  Google Scholar 

  29. Wallace DK, Freedman SF, Zhao Z (2009) A pilot study using ROPtool to measure retinal vascular dilation. Retina 29(8):1182–1187

    Article  PubMed  Google Scholar 

  30. Murakami Y et al (2010) Stanford University Network for Diagnosis of Retinopathy of Prematurity (SUNDROP): 24-month experience with telemedicine screening. Acta Ophthalmol 88(3):317–322

    PubMed  Google Scholar 

  31. Seiberth V et al (1995) Diode laser photocoagulation for stage 3+ retinopathy of prematurity. Graefes Arch Clin Exp Ophthalmol 233(8):489–493

    Article  PubMed  CAS  Google Scholar 

  32. McNamara JA et al (1992) Diode laser photocoagulation for retinopathy of prematurity. preliminary results. Arch Ophthalmol 110(12):1714–1716

    Article  PubMed  CAS  Google Scholar 

  33. Banach MJ, Ferrone PJ, Trese MT (2000) A comparison of dense versus less dense diode laser photocoagulation patterns for threshold retinopathy of prematurity. Ophthalmology 107(2):324–327, discussion 328

    Article  PubMed  CAS  Google Scholar 

  34. Tsitsis T et al (1997) Diode laser photocoagulation for retinopathy of prematurity. Trans Am Ophthalmol Soc 95:231–236, discussion 237–45

    PubMed  CAS  Google Scholar 

  35. Shalev B, Farr AK, Repka MX (2001) Randomized comparison of diode laser photocoagulation versus cryotherapy for threshold retinopathy of prematurity: seven-year outcome. Am J Ophthalmol 132(1):76–80

    Article  PubMed  CAS  Google Scholar 

  36. Cryotherapy for Retinopathy of Prematurity Cooperative Group (2002) Multicenter trial of cryotherapy for retinopathy of prematurity: natural history ROP: ocular outcome at 5(1/2) years in premature infants with birth weights less than 1251 g. Arch Ophthalmol 120(5):595–599

    Google Scholar 

  37. Connolly BP et al (2002) A comparison of laser photocoagulation with cryotherapy for threshold retinopathy of prematurity at 10 years: part 2. Refractive outcome. Ophthalmology 109(5):936–941

    Article  PubMed  Google Scholar 

  38. Ng EY et al (2002) A comparison of laser photocoagulation with cryotherapy for threshold retinopathy of prematurity at 10 years: part 1. Visual function and structural outcome. Ophthalmology 109(5):928–934, discussion 935

    Article  PubMed  Google Scholar 

  39. Early Treatment For Retinopathy Of Prematurity Cooperative (2003) Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial. Arch Ophthalmol 121(12):1684–1694

    Article  Google Scholar 

  40. Good WV et al (2010) Final visual acuity results in the early treatment for retinopathy of prematurity study. Arch Ophthalmol 128(6):663–671

    Article  PubMed  Google Scholar 

  41. McNamara JA (1993) Laser treatment for retinopathy of prematurity. Curr Opin Ophthalmol 4(3):76–80

    Article  PubMed  CAS  Google Scholar 

  42. Banach MJ, Berinstein DM (2001) Laser therapy for retinopathy of prematurity. Curr Opin Ophthalmol 12(3):164–170

    Article  PubMed  CAS  Google Scholar 

  43. Rezai KA et al (2005) Near confluent laser photocoagulation for the treatment of threshold retinopathy of prematurity. Arch Ophthalmol 123(5):621–626

    Article  PubMed  Google Scholar 

  44. Prenner JL, Capone A Jr, Trese MT (2004) Visual outcomes after lens-sparing vitrectomy for stage 4A retinopathy of prematurity. Ophthalmology 111(12):2271–2273

    Article  PubMed  Google Scholar 

  45. Kaiser RS, Trese MT (2001) Iris atrophy, cataracts, and hypotony following peripheral ablation for threshold retinopathy of prematurity. Arch Ophthalmol 119(4):615–617

    PubMed  CAS  Google Scholar 

  46. Lambert SR et al (2000) Cataract and phthisis bulbi after laser photoablation for threshold retinopathy of prematurity. Am J Ophthalmol 129(5):585–591

    Article  PubMed  CAS  Google Scholar 

  47. Simons BD et al (1998) Bilateral hyphemas and cataracts after diode laser retinal photoablation for retinopathy of prematurity. J Pediatr Ophthalmol Strabismus 35(3):185–187

    PubMed  CAS  Google Scholar 

  48. Gaitan JR et al (2008) Anterior segment ischemia following laser therapy for threshold retinopathy of prematurity. Retina 28(3):55–57

    Article  Google Scholar 

  49. Christiansen SP, Bradford JD (1995) Cataract in infants treated with argon laser photocoagulation for threshold retinopathy of prematurity. Am J Ophthalmol 119(2):175–180

    PubMed  CAS  Google Scholar 

  50. Drack AV et al (1992) Transient punctate lenticular opacities as a complication of argon laser photoablation in an infant with retinopathy of prematurity. Am J Ophthalmol 113(5):583–584

    PubMed  CAS  Google Scholar 

  51. Kent D et al (2000) The influence of retinopathy of prematurity on ocular growth. Eye (Lond) 14(1):23–29

    Article  Google Scholar 

  52. Lalwani GA et al (2008) Off-label use of intravitreal bevacizumab (Avastin) for salvage treatment in progressive threshold retinopathy of prematurity. Retina 28(3):13–18

    Article  Google Scholar 

  53. Mintz-Hittner HA, Kuffel RR Jr (2008) Intravitreal injection of bevacizumab (Avastin) for treatment of stage 3 retinopathy of prematurity in zone I or posterior zone II. Retina 28(6):831–838

    Article  PubMed  Google Scholar 

  54. Kusaka S et al (2008) Efficacy of intravitreal injection of bevacizumab for severe retinopathy of prematurity: a pilot study. Br J Ophthalmol 92(11):1450–1455

    Article  PubMed  CAS  Google Scholar 

  55. Quiroz-Mercado H et al (2008) Antiangiogenic therapy with intravitreal bevacizumab for retinopathy of prematurity. Retina 28(3):19–25

    Article  Google Scholar 

  56. Wu WC et al (2011) Effects and complications of bevacizumab use in patients with retinopathy of prematurity: a multicenter study in Taiwan. Ophthalmology 118(1):176–183

    Article  PubMed  Google Scholar 

  57. Mintz-Hittner HA, Kennedy KA, Chuang AZ (2011) Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity. N Engl J Med 364(7):603–615

    Article  PubMed  CAS  Google Scholar 

  58. Shah N et al (2010) The effect of recombinant human erythropoietin on the development of retinopathy of prematurity. Am J Perinatol 27(1):67–71

    Google Scholar 

  59. Connor KM et al (2007) Increased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis. Nat Med 13(7):868–873

    Article  PubMed  CAS  Google Scholar 

  60. Mantagos IS, Vanderveen DK, Smith LE (2009) Emerging treatments for retinopathy of prematurity. Semin Ophthalmol 24(2):82–86

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Bascom Palmer Eye Institute, University of Miami School of Medicine, 900 North West 17th Street, Miami, FL, 33136, USA

    Samuel K. Houston, Charles C. Wykoff, Audina M. Berrocal, Ditte J. Hess & Timothy G. Murray

Authors
  1. Samuel K. Houston
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Charles C. Wykoff
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Audina M. Berrocal
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ditte J. Hess
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Timothy G. Murray
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Timothy G. Murray.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Houston, S.K., Wykoff, C.C., Berrocal, A.M. et al. Laser treatment for retinopathy of prematurity. Lasers Med Sci 28, 683–692 (2013). https://doi.org/10.1007/s10103-011-1021-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10103-011-1021-z

Keywords

Search

Navigation